✦ LIBER ✦

TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics

✍ Scribed by Chou, W.-C.; Chou, S.-C.; Liu, C.-Y.; Chen, C.-Y.; Hou, H.-A.; Kuo, Y.-Y.; Lee, M.-C.; Ko, B.-S.; Tang, J.-L.; Yao, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic impact of DNMT3A mutations in

✍ Jana Marková; Petra Michková; Kateřina Burčková; Jana Březinová; Kyra Michalová; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB

Clinical significance of GSTM1 and GSTT1

✍ Ho Sup Lee; Je-Hwan Lee; Eun-Hye Hur; Michael Jinpyo Lee; Jung-Hee Lee; Dae-Youn 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 252 KB

Plasma hepatocyte growth factor is a pro

✍ Verstovsek, S; Kantarjian, H; Estey, E; Aguayo, A; Giles, F J; Manshouri, T; Kol 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 116 KB

An activating mutation in the transmembr

✍ Forbes, Louisa V; Gale, Rosemary E; Pizzey, Arnold; Pouwels, Karin; Nathwani, Am 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 220 KB

Reduced intensity conditioning prior to

✍ Philipp G. Hemmati; Theis H. Terwey; Gero Massenkeil; Philipp le Coutre; Lam G. 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 243 KB

Improved outcome of patients with low- a

✍ Thomas Prebet; Anne Etienne; Raynier Devillier; Emilie Romeo; Aude Charbonnier; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 1 views